MedPath
FDA Approval

Aurovela 1.5/30

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 21, 2023
Labeling Type
Human Prescription Drug Label
Norethisterone(1.5 mg in 1 1)
Ethinylestradiol(30 ug in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aurobindo Pharma Limited

Aurobindo Pharma Limited

650381903

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Aurovela 1.5/30

Product Details

NDC Product Code
65862-935
Application Number
ANDA207581
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 21, 2023
Code: 9S44LIC7OJClass: ACTIBQuantity: 1.5 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
.ALPHA.-TOCOPHEROLInactive
Code: H4N855PNZ1Class: IACT
Code: 423D2T571UClass: ACTIBQuantity: 30 ug in 1 1
© Copyright 2025. All Rights Reserved by MedPath